Synonyms: ABBV-CLS-7262 | compound 131 [US20220251123A1]
Compound class:
Synthetic organic
Comment: The structure for fosigotifator was obtained from proposed INN list 129 (August 2023) where it is described as a eukaryotic translation initiation factor 2B (eIF2B) activator. Fosigotifator is one of the prodrug compounds claimed in patent US20220251123A1 [2]. It is likely that this is the Abbvie/Calico oral, CNS-penetrant clinical lead ABBV-CLS-7262, that is designed to activate eIF2B and thereby modulate the integrated stress response (ISR) [4] as a mechanism to treat a range of conditions, including neurodegenerative and metabolic diseases [1,3,5].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[(2S)-1,4-bis[[2-(4-chloro-3-fluorophenoxy)acetyl]amino]-2-bicyclo[2.2.2]octanyl]oxymethyl dihydrogen phosphate |
Synonyms ![]() |
ABBV-CLS-7262 | compound 131 [US20220251123A1] |
Database Links ![]() |
|
CAS Registry No. | 2415715-84-1 (source: WHO INN record) |
GtoPdb PubChem SID | 485206007 |
PubChem CID | 153563259 |
Search Google for chemical match using the InChIKey | IURMHIZNAHLQRX-ANYOXOOPSA-N |
Search Google for chemicals with the same backbone | IURMHIZNAHLQRX |
UniChem Compound Search for chemical match using the InChIKey | IURMHIZNAHLQRX-ANYOXOOPSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IURMHIZNAHLQRX-ANYOXOOPSA-N |